dalcetrapib [orch, phsu]
Review [inpr]
Phase [tmco]
Ii [aapp]
Data [idcn]
Statins [orch, phsu]
Risk [qlco]
Cardiovascular disease [dsyn]
Patients [podg]
Increased [qnco]
Risk [qlco]
low [qlco]
Levels [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Drug Therapy [topp]
cardiovascular events [fndg]
To [qlco]
Covered [ftcn]
Review [inpr]
Review [inpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Compound [qlco]
Focus [spco]
Cholesteryl Ester Transfer Protein [aapp, bacs]
inhibitors [chvf]
Reader [prog]
Gain [qnco]
overview [inpr]
Cholesteryl Ester Transfer Protein [aapp, bacs]
Inhibitor [qlco]
dalcetrapib [orch, phsu]
increases [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
development [phsf]
Cholesteryl Ester Transfer Protein [aapp, bacs]
Inhibitor [qlco]
torcetrapib [orch]
Mortality, Excess [qnco]
Attribute [idcn]
Activation [acty]
Renin-Angiotensin-Aldosterone System [bdsy]
hypertensive [fndg]
effects [qlco]
development [phsf]
Cholesteryl Ester Transfer Protein [aapp, bacs]
inhibitors [chvf]
dalcetrapib [orch, phsu]
anacetrapib [orch, phsu]
ONGOING [idcn]
dalcetrapib [orch, phsu]
Unique [qlco]
Chemical Structure [inpr]
Induce [ftcn]
Conformational change [moft]
Cholesteryl Ester Transfer Protein [aapp, bacs]
Forming [ftcn]
Non [ftcn]
Productivity [qnco]
Cholesteryl Ester Transfer Protein [aapp, bacs]
High Density Lipoprotein Cholesterol [bacs, lipd]
Complex [qlco]
Cholesteryl Ester Transfer Protein [aapp, bacs]
inhibitors [chvf]
dalcetrapib [orch, phsu]
Potential [qlco]
Cholesteryl Ester Transfer Protein [aapp, bacs]
Inhibitor [qlco]
Three [qnco]
Cholesteryl Ester Transfer Protein [aapp, bacs]
activity [dora]
mg% [qnco]
Dose [qnco]
Not [ftcn]
Increase [ftcn]
Blood Pressure [orgf]
aldosterone levels [lbtr]
weeks [tmco]
Follow-up [fndg]
mg% [qnco]
Dose [qnco]
dalcetrapib [orch, phsu]
Moving [orgf]
Forward [spco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Alone [qnco]
Combination [qlco]
Statin [orch, phsu]
Little NOS [cgab, dsyn]
Effect [qlco]
Low density lipoprotein cholesterol level [lbpr]
Take [hlca]
Home [cnce]
Message [inpr]
regulatory [rnlw]
Approval [qlco]
Grant [qnco]
Result [ftcn]
ONGOING [idcn]
DAL [carb, phsu]
Outcome [ftcn]
Trial [resa]
Evaluate [ftcn]
effects [qlco]
dalcetrapib [orch, phsu]
mg% [qnco]
Daily [tmco]
standard therapy [topp]
Statin [orch, phsu]
Mortality [qnco]
Morbidity [qnco]
High Risk [qlco]
CHD [topp]
Patients [podg]
Needed [qlco]
dalcetrapib [orch, phsu]
Evaluation [ftcn]
Atherosclerosis [dsyn]
reverse cholesterol transport [celf]
Program [cnce]
Includes [ftcn]
Three [qnco]
Surrogate End Point [qlco]
Trial [resa]
DAL [carb, phsu]
Vessel [bpoc]
DAL [carb, phsu]
Plaque [dsyn]
DAL [carb, phsu]
Plaque [dsyn]
Provide [acty]
Further [spco]
Information [idcn]
Contribution [acty]
Cholesteryl Ester Transfer Protein [aapp, bacs]
Cardiovascular disease [dsyn]
